A carregar...
PCSK9 Monoclonal Antibodies: An Overview
PCSK9 monoclonal antibodies are novel lipid-lowering therapy that have been extensively studied in patients with hypercholesterolemia either as monotherapy or as an add-on to other LLTs. PCSK9 monoclonal antibodies have significantly reduced the low-density lipoprotein cholesterol (LDL-C) plasma lev...
Na minha lista:
| Publicado no: | Heart Views |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer - Medknow
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7507904/ https://ncbi.nlm.nih.gov/pubmed/33014302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_20_20 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|